Long-term company sentiment over time: Gilead Sciences Inc. of the NASDAQ-100 Index
Loading sentiment analysis graphs, please do not refresh the page...
Description of Gilead Sciences Inc.
Gilead Sciences Inc. is a biopharmaceutical company that focuses on developing innovative therapies to treat and prevent infectious diseases, liver diseases, inflammatory diseases, and cancer. Their main activities include researching, developing, and marketing medications to address unmet medical needs around the world. Gilead is known for their advancements in HIV/AIDS treatment, with medications like Truvada and Descovy, as well as for developing therapies for hepatitis C such as Sovaldi and Harvoni. They also have a strong portfolio in the areas of cardiovascular and respiratory conditions. Gilead continuously works towards advancing scientific research and improving patient outcomes through their pharmaceutical products.
Explore other companies: Pharmaceuticals, Biotechnology & Life Sciences
Explore similar companies within the same industry to better understand their company sentiment trends.